Encompass Health Corporation
EHC
Rang in aandelen
#1809
Encompass Health Corporation delivers a range of post-acute healthcare services... Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Aandeelprijs
$120.57
Marktkapitalisatie
$11.89B
Verandering (1 dag)
-1.10%
Verandering (1 jaar)
-3.70%
Land
US
Handel Encompass Health Corporation (EHC)
Categorie
Healthcare
Winst voor Encompass Health Corporation (EHC)
Winst in Jun 2026 TTM: $1.03B
Volgens de meest recente financiële verslagen van Encompass Health Corporation bedraagt de huidige winst van het bedrijf $1.03B. In 2024 behaalde het bedrijf een winst van $749.60M, een stijging ten opzichte van de winst van 2023, die $607.20M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Encompass Health Corporation van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $1.03B | 7.86% |
| 2025 | $953.00M | 27.13% |
| 2024 | $749.60M | 23.45% |
| 2023 | $607.20M | 34.69% |
| 2022 | $450.80M | -10.73% |
| 2021 | $505.00M | 43.10% |
| 2020 | $352.90M | -37.24% |
| 2019 | $562.30M | 14.01% |
| 2018 | $493.20M | -0.64% |
| 2017 | $496.40M | 2.99% |
| 2016 | $482.00M | 21.84% |
| 2015 | $395.60M | 2.25% |
| 2014 | $386.90M | -2.10% |
| 2013 | $395.20M | 16.24% |
| 2012 | $340.00M | 39.98% |
| 2011 | $242.90M | 27.91% |
| 2010 | $189.90M | 53.77% |
| 2009 | $123.50M | -36.83% |
| 2008 | $195.50M | -257.53% |
| 2007 | $-124.10M | -75.88% |
| 2006 | $-514.60M | 40.22% |
| 2005 | $-367.00M | 158.46% |
| 2004 | $-141.99M | -71.53% |
| 2003 | $-498.79M | 37.07% |
| 2002 | $-363.90M | 121.13% |
| 2001 | $-164.56M | -62.13% |
| 2000 | $-434.50M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $9.87B | 860.31% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 276.01% |
US
|
|
| $687.82M | -33.08% |
SA
|
|
| $1.25B | 21.29% |
BR
|
